CBG authorized for use in cosmetics by the European Union
The European Commission has added cannabigerol (CBG) to the EU's cosmetic ingredients database (Cosing), meaning that this compound is safe for use in health and beauty products.
The CBG acts on the CB1 and CB2 endocannabinoid receptors located in the skin. Cannabigerol has anti-inflammatory, antibacterial and antioxidant properties that help the endocannabinoid system maintain healthy skin function.
Once CBG penetrates the epidermis, it reaches the basal and subcutaneous layers of the skin, where it helps calm inflammation, reduce blemishes, purify pores, balance sebum production and improve cell renewal.
CBG is known as the «mother» cannabinoid, the precursor of all other cannabinoids such as CBD, CBN, CBC or THC in their acid form.
CBD of natural origin, which has been added to the Cosing database at the beginning of the year, and synthetic CBD, are also authorized for use in EU cosmetics, just like hemp leaves.
CBG registration at Cosing can be seen here.
The «cannabis» fine raised to 500 euros under the RIPOST Act
Sacha Baron Cohen Brings Ali G Back to Life During a Surprise Appearance at Wimbledon
Botswana Paves the Way for Commercial Hemp Cultivation
The First Authorized Medical Cannabis Cultivation in the Canary Islands
Germany Ends Public Health Insurance Coverage for Medical Cannabis Flowers
Cannabis Legalization in Pennsylvania Once Again on Hold
Democratic senators are reviving a bill to legalize cannabis at the federal level in the United States
A THC:CBD oil shows promising results in reducing agitation in people with dementia
San Francisco Allows «Cannabis Cafés»
Kenya Denies Rastafarians the Right to Use Cannabis
-
Cannabis in Europe4 weeks agoBosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange
You must be logged in to post a comment Login